Emily S Day - Publications

2013- Biomedical Engineering University of Delaware, Newark, DE, United States 

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Kapadia CH, Luo B, Dang MN, Irvin-Choy N, Valcourt DM, Day ES. Polymer nanocarriers for MicroRNA delivery. Journal of Applied Polymer Science. 137. PMID 33384460 DOI: 10.1002/app.48651  0.64
2020 Dang MN, Gomez Casas C, Day ES. Photoresponsive miR-34a/Nanoshell Conjugates Enable Light-Triggered Gene Regulation to Impair the Function of Triple-Negative Breast Cancer Cells. Nano Letters. PMID 33306406 DOI: 10.1021/acs.nanolett.0c03152  0.32
2020 Wang J, Dang MN, Day ES. Inhibition of Wnt signaling by Frizzled7 antibody-coated nanoshells sensitizes triple-negative breast cancer cells to the autophagy regulator chloroquine. Nano Research. 13: 1693-1703. PMID 33304449 DOI: 10.1007/s12274-020-2795-8  0.32
2020 Nelson KM, Irvin-Choy N, Hoffman MK, Gleghorn JP, Day ES. Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies. Advanced Drug Delivery Reviews. PMID 33002575 DOI: 10.1016/j.addr.2020.09.013  0.44
2020 Valcourt DM, Day ES. Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers. Molecular Therapy. Nucleic Acids. 21: 290-298. PMID 32622330 DOI: 10.1016/j.omtn.2020.06.003  0.6
2020 Irvin-Choy NS, Nelson KM, Gleghorn JP, Day ES. Design of nanomaterials for applications in maternal/fetal medicine. Journal of Materials Chemistry. B. PMID 32452510 DOI: 10.1039/d0tb00612b  0.44
2020 Valcourt DM, Kapadia CH, Scully MA, Dang MN, Day ES. Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines. Advanced Healthcare Materials. e2000110. PMID 32367687 DOI: 10.1002/adhm.202000110  0.64
2020 Valcourt DM, Dang MN, Scully MA, Day ES. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer. Acs Nano. PMID 32083466 DOI: 10.1021/acsnano.9b09263  0.6
2020 Wang J, Potocny AM, Rosenthal J, Day ES. Gold Nanoshell-Linear Tetrapyrrole Conjugates for Near Infrared-Activated Dual Photodynamic and Photothermal Therapies. Acs Omega. 5: 926-940. PMID 31956847 DOI: 10.1021/acsomega.9b04150  0.32
2019 Kapadia CH, Ioele SA, Day ES. Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells. Journal of Biomedical Materials Research. Part A. PMID 31742868 DOI: 10.1002/jbm.a.36840  1
2019 Valcourt DM, Dang MN, Wang J, Day ES. Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer. Annals of Biomedical Engineering. PMID 31686312 DOI: 10.1007/s10439-019-02399-7  0.6
2019 Valcourt DM, Dang MN, Day ES. IR820-Loaded PLGA Nanoparticles for Photothermal Therapy of Triple-Negative Breast Cancer. Journal of Biomedical Materials Research. Part A. PMID 30920169 DOI: 10.1002/jbm.a.36685  0.6
2018 Valcourt DM, Harris J, Riley RS, Dang M, Wang J, Day ES. Advances in targeted nanotherapeutics: From bioconjugation to biomimicry. Nano Research. 11: 4999-5016. PMID 31772723 DOI: 10.1007/s12274-018-2083-z  0.76
2018 Goyal R, Kapadia CH, Melamed JR, Riley RS, Day ES. Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a. Cellular and Molecular Bioengineering. 11: 383-396. PMID 30555597 DOI: 10.1007/s12195-018-0535-x  1
2018 Melamed JR, Ioele SA, Hannum AJ, Ullman VM, Day ES. Polyethylenimine-Spherical Nucleic Acid Nanoparticles Against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells. Molecular Pharmaceutics. PMID 30260647 DOI: 10.1021/acs.molpharmaceut.8b00707  1
2018 Melamed JR, Kreuzberger NL, Goyal R, Day ES. Spherical Nucleic Acid Architecture Can Improve the Efficacy of Polycation-Mediated siRNA Delivery. Molecular Therapy. Nucleic Acids. 12: 207-219. PMID 30195760 DOI: 10.1016/j.omtn.2018.05.008  1
2018 Riley RS, O'Sullivan RK, Potocny AM, Rosenthal J, Day ES. Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells. Nanomaterials (Basel, Switzerland). 8. PMID 30149630 DOI: 10.3390/nano8090658  0.76
2018 Potocny AM, Riley RS, O'Sullivan RK, Day ES, Rosenthal J. Photochemotherapeutic Properties of a Linear Tetrapyrrole Palladium(II) Complex displaying an Exceptionally High Phototoxicity Index. Inorganic Chemistry. PMID 30132325 DOI: 10.1021/acs.inorgchem.8b01225  0.76
2018 Riley RS, Melamed JR, Day ES. Enzyme-Linked Immunosorbent Assay to Quantify Targeting Molecules on Nanoparticles. Methods in Molecular Biology (Clifton, N.J.). 1831: 145-157. PMID 30051430 DOI: 10.1007/978-1-4939-8661-3_11  1
2018 Kapadia CH, Melamed JR, Day ES. Spherical Nucleic Acid Nanoparticles: Therapeutic Potential. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 29959665 DOI: 10.1007/s40259-018-0290-5  1
2018 Melamed JR, Morgan JT, Ioele SA, Gleghorn JP, Sims-Mourtada J, Day ES. Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide. Oncotarget. 9: 27000-27015. PMID 29930746 DOI: 10.18632/oncotarget.25467  1
2018 Riley RS, Dang MN, Billingsley MM, Abraham B, Gundlach L, Day ES. Evaluating the Mechanisms of Light-Triggered siRNA Release from Nanoshells for Temporal Control Over Gene Regulation. Nano Letters. PMID 29701993 DOI: 10.1021/acs.nanolett.8b00681  0.76
2017 Riley RS, Day ES. Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells. Small (Weinheim An Der Bergstrasse, Germany). PMID 28544579 DOI: 10.1002/smll.201700544  0.76
2017 Billingsley MM, Riley RS, Day ES. Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods. Plos One. 12: e0177592. PMID 28494030 DOI: 10.1371/journal.pone.0177592  0.76
2017 Petrosko SH, Day ES. Erratum. Methods in Molecular Biology (Clifton, N.J.). 1570: E1. PMID 28474312 DOI: 10.1007/978-1-4939-6840-4_23  0.48
2017 Melamed JR, Riley RS, Valcourt DM, Billingsley MM, Kreuzberger NL, Day ES. Quantification of siRNA Duplexes Bound to Gold Nanoparticle Surfaces. Methods in Molecular Biology (Clifton, N.J.). 1570: 1-15. PMID 28238126 DOI: 10.1007/978-1-4939-6840-4_1  1
2017 Riley RS, Day ES. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 28160445 DOI: 10.1002/wnan.1449  0.76
2016 Melamed JR, Riley RS, Valcourt DM, Day ES. Using Gold Nanoparticles To Disrupt the Tumor Microenvironment: An Emerging Therapeutic Strategy. Acs Nano. 10: 10631-10635. PMID 28024339 DOI: 10.1021/acsnano.6b07673  1
2015 Fay BL, Melamed JR, Day ES. Nanoshell-mediated photothermal therapy can enhance chemotherapy in inflammatory breast cancer cells. International Journal of Nanomedicine. 10: 6931-41. PMID 26609231 DOI: 10.2147/IJN.S93031  1
2015 Kouri FM, Hurley LA, Daniel WL, Day ES, Hua Y, Hao L, Peng CY, Merkel TJ, Queisser MA, Ritner C, Zhang H, James CD, Sznajder JI, Chin L, Giljohann DA, et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes & Development. 29: 732-45. PMID 25838542 DOI: 10.1101/gad.257394.114  0.8
2015 Melamed JR, Edelstein RS, Day ES. Elucidating the fundamental mechanisms of cell death triggered by photothermal therapy. Acs Nano. 9: 6-11. PMID 25590560 DOI: 10.1021/acsnano.5b00021  1
2013 Jensen SA, Day ES, Ko CH, Hurley LA, Luciano JP, Kouri FM, Merkel TJ, Luthi AJ, Patel PC, Cutler JI, Daniel WL, Scott AW, Rotz MW, Meade TJ, Giljohann DA, et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Science Translational Medicine. 5: 209ra152. PMID 24174328 DOI: 10.1126/scitranslmed.3006839  0.8
2012 Day ES, Zhang L, Thompson PA, Zawaski JA, Kaffes CC, Gaber MW, Blaney SM, West JL. Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine (London, England). 7: 1133-48. PMID 22583571 DOI: 10.2217/nnm.11.189  0.8
2011 Kennedy LC, Bickford LR, Lewinski NA, Coughlin AJ, Hu Y, Day ES, West JL, Drezek RA. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small (Weinheim An Der Bergstrasse, Germany). 7: 169-83. PMID 21213377 DOI: 10.1002/smll.201000134  0.8
2011 Day ES, Thompson PA, Zhang L, Lewinski NA, Ahmed N, Drezek RA, Blaney SM, West JL. Nanoshell-mediated photothermal therapy improves survival in a murine glioma model. Journal of Neuro-Oncology. 104: 55-63. PMID 21110217 DOI: 10.1007/s11060-010-0470-8  0.8
2010 Day ES, Bickford LR, Slater JH, Riggall NS, Drezek RA, West JL. Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer. International Journal of Nanomedicine. 5: 445-54. PMID 20957166  0.8
2010 Morton JG, Day ES, Halas NJ, West JL. Nanoshells for photothermal cancer therapy. Methods in Molecular Biology (Clifton, N.J.). 624: 101-17. PMID 20217591 DOI: 10.1007/978-1-60761-609-2_7  0.8
2009 Rostro-Kohanloo BC, Bickford LR, Payne CM, Day ES, Anderson LJ, Zhong M, Lee S, Mayer KM, Zal T, Adam L, Dinney CP, Drezek RA, West JL, Hafner JH. The stabilization and targeting of surfactant-synthesized gold nanorods. Nanotechnology. 20: 434005. PMID 19801751 DOI: 10.1088/0957-4484/20/43/434005  0.8
2009 Day ES, Morton JG, West JL. Nanoparticles for thermal cancer therapy. Journal of Biomechanical Engineering. 131: 074001. PMID 19640133 DOI: 10.1115/1.3156800  0.8
2006 Lowery AR, Gobin AM, Day ES, Halas NJ, West JL. Immunonanoshells for targeted photothermal ablation of tumor cells. International Journal of Nanomedicine. 1: 149-54. PMID 17722530 DOI: 10.2147/nano.2006.1.2.149  0.8
Show low-probability matches.